Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colorectal Carcinoma (mCRC)”

317 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 317 results

Testing effectiveness (Phase 2)Study completedNCT03898102
What this trial is testing

Zinc Supplement in Regorafenib Treated mCRC Patient

Who this might be right for
Colorectal Cancer Metastatic
Chang Gung Memorial Hospital 65
Not applicableUnknownNCT01756625
What this trial is testing

PREMIUM, Observational Study

Who this might be right for
First Line WT KRAS mCRC
Dr.Laurent Mineur 500
Early research (Phase 1)Study completedNCT03616574
What this trial is testing

First-in-human Study of CA102N Monotherapy and CA102N Combined With Trifluridine/Tipiracil (LONSURF) in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsAdvanced or Metastatic Colorectal Cancer (mCRC)
Holy Stone Healthcare Co., Ltd 37
Testing effectiveness (Phase 2)UnknownNCT05438108
What this trial is testing

SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab in First-line Treatment of mCRC

Who this might be right for
Metastatic Colorectal Cancer
Huazhong University of Science and Technology 30
Not applicableLooking for participantsNCT07224724
What this trial is testing

Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Cancer Liver Metastases (CRLM)Metastatic Colorectal Carcinoma (mCRC)
City of Hope Medical Center 500
Not applicableLooking for participantsNCT07001085
What this trial is testing

CtDNA Monitoring in Patients With HCC and mCRC

Who this might be right for
HCC - Hepatocellular CarcinomaColorectal Cancer Metastatic
Medical University of Warsaw 300
Testing effectiveness (Phase 2)Looking for participantsNCT07012954
What this trial is testing

CtDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC

Who this might be right for
Colorectal Cancer Metastatic
Sun Yat-sen University 64
Testing effectiveness (Phase 2)Looking for participantsNCT07255664
What this trial is testing

A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC

Who this might be right for
Metastatic Colorectal CancerProstate Cancer MetastaticProstate Cancer Locally Advanced
Curacell Holding AB 12
Early research (Phase 1)Study completedNCT00940758
What this trial is testing

Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy

Who this might be right for
Metastatic Colorectal Cancer
PharmaEngine 18
Early research (Phase 1)Study completedNCT02069704
What this trial is testing

Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
mAbxience Research S.L. 142
Large-scale testing (Phase 3)Not Yet RecruitingNCT06959693
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Sun Yat-sen University 590
Post-approval studies (Phase 4)Study completedNCT02800330
What this trial is testing

The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib

Who this might be right for
Colorectal NeoplasmsGastrointestinal Stromal Tumors
Erasmus Medical Center 31
Testing effectiveness (Phase 2)Looking for participantsNCT06699836
What this trial is testing

Leronlimab in Combination With TAS-102 + Bevacizumab in Previously Treated Participants With mCRC

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
CytoDyn, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT00332163
What this trial is testing

Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy

Who this might be right for
Metastatic Colorectal CancerSkin RashSkin Toxicities+2 more
Amgen 95
Testing effectiveness (Phase 2)UnknownNCT05233332
What this trial is testing

Study of HL-085 and Vemurafinib in Metastatic Colorectal Cancer (mCRC)

Who this might be right for
CRC
Shanghai Kechow Pharma, Inc. 186
Not applicableUnknownNCT01754272
What this trial is testing

A Non-Interventional Follow-Up to the VELOUR Study - Translational Research

Who this might be right for
Metastatic Colorectal Cancer
KU Leuven 1,226
Testing effectiveness (Phase 2)Looking for participantsNCT06427005
What this trial is testing

Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC

Who this might be right for
FruquintinibS-1Raltitrexed
Meng Qiu 66
Testing effectiveness (Phase 2)Study completedNCT02368886
What this trial is testing

Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Colon AdenocarcinomaRectal AdenocarcinomaStage III Colorectal Cancer AJCC v7+6 more
Academic and Community Cancer Research United 123
Not applicableEnded earlyNCT02511756
What this trial is testing

Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP)

Who this might be right for
Metastatic Colorectal Cancer
Patrick Veit-Haibach 50
Testing effectiveness (Phase 2)WithdrawnNCT05730673
What this trial is testing

Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer

Who this might be right for
CCR5Microsatellite StableMetastatic+1 more
CytoDyn, Inc.
Load More Results